Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Gross Margin (2018 - 2025)

Historic Gross Margin for Selectis Health (GBCS) over the last 8 years, with Q3 2025 value amounting to 21.41%.

  • Selectis Health's Gross Margin fell 29800.0% to 21.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.63%, marking a year-over-year increase of 15800.0%. This contributed to the annual value of 23.13% for FY2024, which is 84300.0% up from last year.
  • Latest data reveals that Selectis Health reported Gross Margin of 21.41% as of Q3 2025, which was down 29800.0% from 21.89% recorded in Q2 2025.
  • Selectis Health's 5-year Gross Margin high stood at 39.69% for Q3 2021, and its period low was 11.41% during Q1 2023.
  • Over the past 5 years, Selectis Health's median Gross Margin value was 22.57% (recorded in 2021), while the average stood at 23.46%.
  • Its Gross Margin has fluctuated over the past 5 years, first tumbled by -257000bps in 2021, then skyrocketed by 163500bps in 2022.
  • Over the past 5 years, Selectis Health's Gross Margin (Quarter) stood at 13.08% in 2021, then surged by 51bps to 19.75% in 2022, then dropped by -20bps to 15.87% in 2023, then soared by 53bps to 24.34% in 2024, then fell by -12bps to 21.41% in 2025.
  • Its Gross Margin stands at 21.41% for Q3 2025, versus 21.89% for Q2 2025 and 22.94% for Q1 2025.